The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07590570

Enrollment

188

Registered

2026-05-15

Start date

2026-05-01

Completion date

2033-01-01

Last updated

2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Invasive

Brief summary

This is a multicentre study to investigate the association of fingernail lunula status with the efficacy and safety of neoadjuvant therapy in breast cancer patients.

Interventions

DRUGneoadjuvant therapy

patients receiving neoadjuvant therapy

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Aged 18 years or older * Pathologically confirmed invasive primary breast cancer * Patients who have received or are scheduled to receive neoadjuvant therapy

Exclusion criteria

* De novo stage IV breast cancer

Design outcomes

Primary

Measure	Time frame	Description
Pathological Complete Response (pCR) Rate	at surgery	ypT0 ypN0

Secondary

Measure	Time frame	Description
Disease-free Survival	From surgery until time of event up to 8 years	Disease-free survival time is defined as the time from date of randomization until the first occurrence of disease recurrence, distant metastasis and death from any cause.

Countries

China

Contacts

PRINCIPAL_INVESTIGATORWenjin Yin

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026